Journal Of Clinical Oncology (jco) Podcast
Dexamethasone and High-Dose Methotrexate in High-Risk B Cell Acute Lymphoblastic Leukemia—Where Should We Go From Here?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:10:32
- Mas informaciones
Informações:
Sinopsis
The Children's Oncology Group study led by Larsen et al. showed that children and young adult patients with high-risk B cell acute lymphoblastic leukemia benefit from receiving high-dose methotrexate during interim maintenance 1 and that those aged 1 to 9 years benefit from receiving dexamethasone for 14 days during induction.
